Skip to content
OpenCapital
Get started

Caribou Biosciences, Inc. CRBU Q4 2024 Annual earnings

Reported March 10, 2025 · Before market open

Revenue$2.1MMiss by $29.3K
EPS-$0.39Beat by $0.01
Revenue estimate$2.1M
EPS estimate-$0.40

Next report

Aug 12, 2026 (In 2 weeks)
Revenue estimate$2.3M
EPS estimate-$0.33

Versus estimates

Revenue

Q1 2026$2.4MBeat by $184.4KQ4 2025$3.9MBeat by $1.7MQ3 2025$2.2MBeat by $241.0KQ2 2025$2.7MBeat by $1.1MQ1 2025$2.4MBeat by $501.6K
Q4 2024$2.1MMiss by $29.3K

Diluted EPS

Q1 2026-$0.26Beat by $0.07Q4 2025-$0.28Beat by $0.05Q3 2025-$0.30Beat by $0.06Q2 2025-$0.35Beat by $0.05Q1 2025-$0.43In line
Q4 2024-$0.39Beat by $0.01

Ask the moment Caribou Biosciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Caribou Biosciences, Inc. report Q4 2024 earnings?
Caribou Biosciences, Inc. (CRBU) reported Q4 2024 earnings on March 10, 2025 before market open.
What were Caribou Biosciences, Inc.'s Q4 2024 revenue and EPS?
Caribou Biosciences, Inc. reported revenue of $2.1M and eps of $-0.39 for Q4 2024.
Did Caribou Biosciences, Inc. beat estimates in Q4 2024?
Revenue missed the consensus estimate of $2.1M by $29.3K. EPS beat the consensus estimate of $-0.40 by $0.01.
Where can I find Caribou Biosciences, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001619856-25-000015) directly on SEC EDGAR. The filing index links above go to sec.gov.